Atrial Fibrillation

Anesthesiology Clinics of North America

Volumn 24, Issue 3, 2006, Pages 509-522

  Garwood, Susan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUTILIDE; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; PROPAFENONE; SOTALOL; VERAPAMIL; WARFARIN;

BRADYCARDIA; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; DRUG INDICATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SURGERY; HUMAN; HYPERTENSION; META ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT PLANNING;

ATRIAL FIBRILLATION; COMORBIDITY; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; THROMBOSIS;

EID: 33748793927     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2006.05.004     Document Type: Review

References (53)

1. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 104 17 (2001) 2118-2150
2. Feinberg W.M., Blackshear J.L., Laupacis A., et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 155 5 (1995) 469-473
3. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 9 (2004) 1042-1046
4. Ryder K.M., and Benjamin E.J. Epidemiology and significance of atrial fibrillation. Am J Cardiol 84 Suppl 1 (1999) 131-138
5. Vidaillet H., Granada J.F., Chyou P.-H., et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 113 5 (2002) 365-370
6. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 18 (2001) 2370-2375
7. Wolf P.A., Benjamin E.J., Belanger A.J., et al. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 131 4 (1996) 790-795
8. Friberg J., Scharling H., Gadsboll N., et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol 92 12 (2003) 1419-1423
9. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 6 7 (1997) 2455-2461
10. Vidaillet H.J., Chyou P.-H., Granada J., et al. Mortality of primary versus secondary atrial fibrillation: a population based study from the Marshfield Epidemiological Study Area. [abstract]. Pacing Clin Electrophysiol 26 1001 (2003) Abstract #292
11. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 10 (1998) 946-952
12. Stewart S., Hart C.L., Hole D.J., et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley Study. Am J Med 113 5 (2002) 359-364
13. Pederson O.D., Bagger H., Keller N., et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy. Circulation 104 (2001) 292-296
14. The AFFIRM investigators. Relationships between sinus rRhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109 12 (2004) 1509-1513
15. Mehta R.H., Dabbous O.H., Granger C.B., et al. (GRACE investigators). Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 92 9 (2003) 1031-1036
16. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 23 (2003) 2920-2925
17. Ahmed A., Thornton P., Perry G.J., et al. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 6 4 (2004) 421-426
18. Murthy S.C., Law S., Whooley B.P., et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 126 4 (2003) 1162-1167
19. Vaporciyan A.A., Correa A.M., Rice D.C., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127 3 (2004) 779-786
20. Dixon B.J., Bracha Y., Loecke S.W., et al. Principal atrial fibrillation discharges by the new ACC/AHA/ESC classification. Arch Intern Med 165 16 (2005) 1877-1881
21. Levy S., Camm A.J., Saksens S., et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 14 4 (2003) 443-445
22. Wyse G.D. Rate control vs rhythm control strategies in atrial fibrillation. Prog Cardiovasc Dis 48 2 (2005) 125-138
23. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
24. Rawles J.M. What is meant by a "controlled" ventricular heart rate in atrial fibrillation?. Br Heart J 63 (1990) 157-161
25. Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 8 (2003) 1049-1056
26. Conway D.S., Heeringa J., Van Der Kuip D.A., et al. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Stroke 34 2 (2003) 413-417
27. Waldo A.L., Becker R.C., Tapson V.F., et al. NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 9 (2005) 1729-1736
28. Albers G.W., Dalen J.E., Laupacis A., et al. Antithrombotic therapy in atrial fibrillation. Chest 119 (2001) 194S-206S
29. Nair A., Hazell W., Sutton T., et al. Antithrombotic therapy in atrial fibrillation: an assessment of compliance with guidelines. N Z Med J 118 1208 (2005) 1258-1263
30. Paciaroni M., Agnelli G., Caso V., et al. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost 3 6 (2005) 1218-1223
31. Anderson D.R., Gardner M.J., Putnam W., et al. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation. Can J Cardiol 21 3 (2005) 257-266
32. Snow V., Weiss K.B., LeFevre M., et al. AAFP Panel on Atrial Fibrillation. ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 139 12 (2003) 1009-1017
33. Blacker D.J., Wijdicks E.F., and McClelland R.L. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61 7 (2003) 964-968
34. Baker R.I., Coughlin P.B., Gallus A.S., et al. Warfarin Reversal Consensus Group. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181 9 (2004) 492-497
35. McKeown P.P., and Gutterman D. American College of Chest Physicians. Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 Suppl 2 (2005) 1S-5S
36. Von Knorring J., Lepantalo M., Lindgren L., et al. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg 48 (1989) 33-37
37. Bailey C.C., and Betts R.H. Cardiac arrythmias following pneumonectomy. N Engl J Med 229 (1943) 356-359
38. Reed C.E., Dorman B.H., and Spinale F.G. Mechanisms of right ventricular dysfunction after pulmonary resection. Ann Thorac Surg 62 (1996) 225-232
39. Backlund M., Laasonen L., Lepantalo M., et al. Effect of oxygen on pulmonary hemodynamics and incidence of atrial fibrillation after noncardiac thoracotomy. J Cardiothorac Vasc Anesth 12 4 (1998) 422-428
40. von Knorring J., Lepantalo M., Lindgren L., et al. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg 53 4 (1992) 642-647
41. Amar D., Zhang H., Miodownik S., et al. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol 42 7 (2003) 1262-1268
42. Cardinale D., Martinoni A., Cipolla C.M., et al. Atrial fibrillation after operation for lung cancer: clinical and prognostic significance. Ann Thorac Surg 68 5 (1999) 1827-1831
43. Neustein S.M., Kahn P., Krellenstein D.J., et al. Incidence of arrhythmias after thoracic surgery: thoracotomy versus video-assisted thoracoscopy. J Cardiothorac Vasc Anesth 12 6 (1998) 659-661
44. Jakobsen C.J., Bille S., Ahlburg P., et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 11 6 (1997) 746-751
45. Lanza L.A., Visbal A.I., DeValeria P.A., et al. Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection. Ann Thorac Surg 75 1 (2003) 223-230
46. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 10 (1997) 3542-3548
47. Amar D., Fleisher M., and Zhang H. Elevated C-reactive protein but not troponin is associated with postoperative atrial fibrillation. Anesth Analg 94 (2002) S-67
48. Dotani M.I., Elnicki D.M., Jain A.C., et al. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 86 10 (2000) 1128-1130
49. Young-Xu Y., Jabbour S., Goldberg R., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 12 (2003) 1379-1383
50. Siu C.-W., Lau C.-P., and Tse H.-F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92 11 (2003) 1343-1345
51. Amar D., Zhang H., Heerdt P.M., et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128 5 (2005) 3421-3427
52. Barbetakis N., and Vassiliadis M. Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?. BMC Surg 4 (2004) 7-12
53. Kahn R.L., Hargertt M.J., Urquart B., et al. Supraventricular tachyarrhythmias during total joint arthroplasty. Incidence and clinical risk. Clin Orthop 296 (1993) 265-269